InspireMD, Inc. announced plans to align its operations and leadership with focus on its commercial markets in line with the continued execution of its carotid and neurovascular strategy which was launched in mid 2015. Key elements of the changes announced include the recruitment of a new CEO, who will focus on the company's immediate commercial and development activities in Europe in order to enhance operational efficiency and further improve the company's cost structure. To ensure a smooth leadership transition, the company's current CEO, Alan Milinazzo, has agreed to remain through the earlier of the appointment of the new CEO or June 30, 2016.

The company also announced that Isaac Blech joins the company as Vice Chairman of the Board. Mr. Blech brings with him over 30 years of experience as a healthcare industry pioneer and investor, developing companies from early to profitable commercial stages, including multiple successful strategic acquisitions.